Pulmonary Hypertension and Atrial Septal Defect: Management Dilemma

Am J Ther. 2017 Sep/Oct;24(5):e602-e605. doi: 10.1097/MJT.0000000000000472.

Abstract

The decision making in patients with an atrial septal defect (ASD) in setting of pulmonary hypertension is complex. In the era of pulmonary arterial vasodilator therapy, every patient should undergo evaluation by pulmonary hypertension experts especially if defect closure is being considered. Defect closure in the inappropriate group can lead to poor outcomes.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cardiac Catheterization
  • Dyspnea / etiology
  • Dyspnea / therapy
  • Echocardiography, Doppler
  • Echocardiography, Transesophageal
  • Female
  • Heart Septal Defects, Atrial / complications
  • Heart Septal Defects, Atrial / diagnosis
  • Heart Septal Defects, Atrial / therapy*
  • Heart Ventricles / pathology*
  • Humans
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / diagnosis
  • Hypertension, Pulmonary / therapy*
  • Hypoxia / etiology
  • Hypoxia / therapy
  • Male
  • Middle Aged
  • Postoperative Complications / etiology
  • Pulmonary Artery
  • Reoperation
  • Septal Occluder Device / adverse effects*
  • Therapeutic Occlusion / adverse effects*
  • Therapeutic Occlusion / instrumentation
  • Therapeutic Occlusion / methods
  • Tomography, X-Ray Computed
  • Vasodilator Agents / therapeutic use*
  • Ventricular Function

Substances

  • Vasodilator Agents